Biomarkers in inflammatory bowel disease: current practices and recent advances.

Iskandar, Heba N., Ciorba, Matthew A.·2012·Translational Research
DOI 10.1016/j.trsl.2012.01.001

Cited by (210)

Items 101–200 of 210

  1. Predictive value of faecal calprotectin in ulcerative colitis – single centre experience
    Dora Grgić, Karlo Golubić, Marko Brinar, Željko Krznarić · 2022 · Annals of Medicine
  2. The role of new inflammatory indices in the prediction of endoscopic and histological activity in inflammatory bowel disease patients
    Nicola Cesaro, Marco Valvano, Sabrina Monaco, Gianpiero Stefanelli, Stefano Fabiani, Filippo Vernia, Stefano Necozione, Angelo Viscido, Giovanni Latella · 2024 · European Journal of Gastroenterology & Hepatology
  3. Opportunities and challenges in the therapeutic exploitation of histamine and histamine receptor pharmacology in inflammation-driven disorders
    Ekaterini Tiligada, Charikleia Stefanaki, Madeleine Ennis, Detlef Neumann · 2024 · Pharmacology & Therapeutics
  4. A Proteomics Pipeline for Generating Clinical Grade Biomarker Candidates from Data‐Independent Acquisition Mass Spectrometry (DIA‐MS) Discovery
    Qin Fu, Manasa Vegesna, Niveda Sundararaman, Eugen Damoc, Tabiwang N. Arrey, Anna Pashkova, Emebet Mengesha, Philip Debbas, Sandy Y. Joung, Dalin Li et al. · 2024 · Angewandte Chemie International Edition
  5. A literature review on large intestinal hyperelastic constitutive modeling
    Aroj Bhattarai, Wojciech Kowalczyk, Thanh Ngọc Trần · 2021 · Clinical Biomechanics
  6. Immunohistochemical Analysis of Retinoblastoma and β-Catenin as an Assistant Tool in the Differential Diagnosis between Crohn's Disease and Ulcerative Colitis
    Rossana Colla Soletti, Nathassya Accioly Lins Vidal Rodrigues, Deborah Biasoli, Ronir Raggio Luiz, Heitor Siffert Pereira de Souza, Helena L. Borges · 2013 · PLoS ONE
  7. Relative Defects in Mucosal Immunity Predict Acute Graft-Versus-Host Disease
    Keith J. August, Kuang‐Yueh Chiang, Muna D. Qayed, Ashley Dulson, Diana A. Worthington‐White, Conrad R. Cole, John Horan · 2014 · Transplantation and Cellular Therapy
  8. Anti-Saccharomyces cerevisiae antibodies (ASCA) are associated with body fat mass and systemic inflammation, but not with dietary yeast consumption: a cross-sectional study
    Anne Stine Kvehaugen, Martin Aasbrenn, Per G. Farup · 2017 · BMC Obesity
  9. Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics?
    Jongmin Park · 2014 · World Journal of Gastroenterology
  10. Inflammatory Markers in Children with Newly Diagnosed Inflammatory Bowel Disease
    Andrew Stewart Day, Darcy Hamilton, Steven T. Leach, Daniel A. Lemberg · 2017 · Journal of Gastroenterology and Hepatology Research
  11. Lactobacillus johnsonii glycolipids, their structure and immunoreactivity with sera from inflammatory bowel disease patients
    Mariola Paściak, Sabina Górska, Natalia Jawiarczyk, Andrzej Gamian · 2016 · Microbial Biotechnology
  12. In vivo reprogramming in inflammatory bowel disease
    A. Wagnerová, R. Gardlík · 2013 · Gene Therapy
  13. Fecal acute phase proteins in cats with chronic enteropathies
    Dimitra A. Karra, Christopher C. Chadwick, Evangelia M. Stavroulaki, Matina N. Pitropaki, Eugenia S. Flouraki, Karin Allenspach, Jonathan A. Lidbury, Jöerg M. Steiner, Panagiotis G. Xenoulis · 2023 · Journal of Veterinary Internal Medicine
  14. Utility of Biomarkers in the Management of Inflammatory Bowel Disease
    Gursimran Singh Kochhar, Bret A. Lashner · 2017 · Current Treatment Options in Gastroenterology
  15. Combining pharmacometric models with predictive and prognostic biomarkers for precision therapy in Crohn's disease: A case study of brazikumab
    Nan Zhang, Ming Liang Chan, Jing Li, Philip Z. Brohawn, Bo Sun, Inna Vainshtein, Lorin K. Roskos, Raffaella Faggioni, Radojka M. Savić · 2023 · CPT Pharmacometrics & Systems Pharmacology
  16. Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain
    Stanisław Pieczarkowski, Kinga Kowalska‐Duplaga, Przemko Kwinta, Przemysław Tomasik, Andrzej Wędrychowicz, Krzysztof Fyderek · 2016 · Gastroenterology Research and Practice
  17. Molecularly Imprinted Polymer Advanced Hydrogels as Tools for Gastrointestinal Diagnostics
    Tatjana Ivaškienė, Greta Kaspute, Arūnas Ramanavičius, Urte Prentice · 2025 · Gels
  18. Elevated urinary orosomucoid excretion as a novel biomarker in Crohn’s disease
    Balázs Szirmay, András Tárnok, Patrícia Sarlós, Nóra Szigeti, Andrea Ludány, Péter Kustán, Zoltán Horváth‐Szalai, Attila Miseta, Tamás Kőszegi · 2018 · European Journal of Clinical Investigation
  19. Gastrointestinal toxicity biomarkers
    Aryamitra A. Banerjee · 2014 · Elsevier eBooks
  20. Use of biomarkers in inflammatory bowel disease
    JUAN EGEA VALENZUELA, Gonzalo Antón Ródenas, Ana Sánchez Martínez · 2019 · Medicina Clínica (English Edition)
  21. Lemann Index for Assessment of Crohn’s Disease: Correlation with the Quality of Life, Endoscopic Disease activity, Magnetic Resonance Index of Activity and C- Reactive Protein
    Vestina Strakšytė, Gediminas Kiudelis, Irina Gineikienė, Dainius Jančiauskas, Algidas Basevičius, Saulius Lukoševičius, Limas Kupčinskas · 2019 · Open Medicine
  22. Using serum peptidomics to discovery the diagnostic marker for different stage of ulcerative colitis
    Zhiwei Miao, Kang Ding, Shuyin Jin, Lin Dai, Chen Dai, Xiang Li · 2020 · Journal of Pharmaceutical and Biomedical Analysis
  23. Unraveling the Protective Effect of Hesperetin In Experimentally Induced Colitis: Inhibition of NF‐κB and NLRP3 Inflammasome Activation
    Marwa Mohanad, Sally A. El Awdan, Basma Emad Aboulhoda, Ahmed Ibrahim Nossier, Wessam H. Elesawy, Maha A.E. Ahmed · 2025 · Journal of Biochemical and Molecular Toxicology
  24. Perceived Use Cases, Barriers, and Requirements for a Smart Health-Tracking Toilet Seat: Qualitative Focus Group Study
    Sander Hermsen, Vera Verbiest, Marije Buijs, Eva Wentink · 2023 · JMIR Human Factors
  25. Роль біомаркерів у діагностиці хронічних запальних захворювань кишечника
    Yu.М. Stepanov, I.V. Psareva · 2017 · GASTROENTEROLOGY
  26. Paradigm shift in biomarker translation: a pipeline to generate clinical grade biomarker candidates from DIA-MS discovery
    Qin Fu, Manasa Vegesna, Niveda Sundararaman, Eugen Damoc, Tabiwang N. Arrey, Anna Pashkova, Emebet Mengesha, Philip Debbas, Sandy Y. Joung, Dalin Li et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Serological and faecal markers of irritable bowel syndrome: a systematic review and meta-analysis
    Grace L. Burns, Freya Roberts, Jasmine A. Wark, Sophie Fowler, Michael P. Jones, Kerith Duncanson, Nicholas Joseph Talley, Simon Keely · 2026 · EBioMedicine
  28. An Overview of Immunosensors and Their Application
    Anil Kumar Gupta, Sambhavi Animesh, Amit Singh · 2023 · Springer eBooks
  29. Predictive Model for Prognosis of Sudden Sensorineural Hearing Loss by Nomogram
    Aidan Dong, Jianhua Peng, Renyu Lin · 2024 · Ear Nose & Throat Journal
  30. Concordancia entre la actividad clínica y los marcadores biológicos en la enfermedad inflamatoria intestinal
    Pablo Miranda García, María Chaparro, Javier P. Gisbert · 2014 · Medicina Clínica
  31. Development of a scoring system for predicting the severity of ulcerative colitis
    Junxiang Zeng, Xiupan Gao, Wensong Ge, Manxiu Huai, Zhi-gang Yang, Ting L. Luo, Limei Gao, Xiujun Pan · 2023 · Arab Journal of Gastroenterology
  32. The pan-microbiome profiling system Taxa4Meta identifies clinical dysbiotic features and classifies diarrheal disease
    Qinglong Wu, Shyam Badu, Sik Yu So, Todd J. Treangen, Tor Savidge · 2023 · Journal of Clinical Investigation
  33. Diagnostic importance of faecal markers in long-term monitoring of anti-TNF- therapy in primary responders with Crohn’s disease
    Liliana Łykowska‐Szuber, Katarzyna Klimczak, Piotr Eder, Iwona Krela‐Kaźmierczak, Kamila Stawczyk‐Eder, Michał Michalak, Adam Studniarek, Tomasz Kościński, Aleksandra Szymczak‐Tomczak, Krzysztof Linke · 2015 · Gastroenterology Review
  34. Search for the Laboratory Parameters of Inflammation In The Serum and Faeces of Patients with Irritable Bowel Syndrome
    Barbara Lisowska‐Myjak, J Muszyński, Hanna Zborowska · 2016 · International Journal of Gastroenterology Research and Practice
  35. Marcadores de actividad en la enfermedad inflamatoria intestinal
    JUAN EGEA VALENZUELA, Gonzalo Antón Ródenas, Ana Sánchez Martínez · 2018 · Medicina Clínica
  36. Overcoming difficulty in diagnosis and differential diagnosis of Crohn’s disease: the potential role of serological and genetic tests
    Zhaoxiu Liu, Bo Shen · 2015 · Expert Review of Molecular Diagnostics
  37. Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure
    Helena Edlund, Ana‐Marija Grišić, Casper Steenholdt, Mark Andrew Ainsworth, Jørn Brynskov, Wilhelm Huisinga, Charlotte Kloft · 2018 · Therapeutic Drug Monitoring
  38. Soluble Syndecan-1: Does This Biomarker Address a Seemingly Insoluble Problem in Inflammatory Bowel Disease?
    Angela M. Patterson · 2015 · Digestive Diseases and Sciences
  39. Current and emerging approaches to manage chronic inflammatory gut disorders
    Katelyn M. Green, Sang‐Min Shin, Ramesh K. Jha, Anand Kumar · 2026 · Frontiers in Cellular and Infection Microbiology
  40. Serum indoxyl sulphate and its relation to albumin and α1-acid glycoprotein as a potential biomarkers of maternal intestinal metabolism during pregnancy and postpartum
    Barbara Lisowska‐Myjak, Hanna Zborowska, Radosław Jaźwiec, Maria Karlińska, Ewa Skarżyńska · 2021 · PLoS ONE
  41. EXPERIMENTAL ULCERATIVE COLITIS: TGF-Β AS A DIAGNOSTIC MARKER
    Omar A Farghaly · 2020 · Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences
  42. Utilizing machine learning with knockoff filtering to extract significant metabolites in Crohn’s disease with a publicly available untargeted metabolomics dataset
    Shoaib Bin Masud, Conor Jenkins, Erika K. Hussey, Seth Elkin-Frankston, Phillip M. Mach, Elizabeth S. Dhummakupt, Shuchin Aeron · 2021 · PLoS ONE
  43. Alteration of stool pH and its association with biomarkers of gut enteropathy among slum-dwelling women of reproductive age in Bangladesh
    Ishita Mostafa, S. M. Tafsir Hasan, Md. Amran Gazi, Md Ashraful Alam, Shah Mohammad Fahim, Kazi Nazmus Saqeeb, Tahmeed Ahmed · 2023 · BMC Women s Health
  44. Medication-related burden among Iraqi patients with ulcerative colitis: a cross-sectional study
    Nawar Abdulridha Abood, Dheyaa Jabbar Kadhim, Raghad Jawad Hussein · 2024 · Journal of Medicine and Life
  45. Evaluation of the concordance between biological markers and clinical activity in inflammatory bowel disease
    Pablo Miranda García, María Chaparro, Javier P. Gisbert · 2015 · Medicina Clínica (English Edition)
  46. Association of fecal calprotectin level with eosinophilic gastrointestinal disease in Iranian pediatrics
    Pejman Rohani, Narjes Raja Beheshti, Hosein Alimadadi, Mohammad Hassan Sohouli · 2022 · Allergy Asthma and Clinical Immunology
  47. Comprehensive Phenotyping in Inflammatory Bowel Disease: Search for Biomarker Algorithms in the Transkingdom Interactions Context
    Ayelén Daiana Rosso, Pablo Aguilera, Sofía Quesada, María Florencia Mascardi, Sebastian Nicolas Mascuka, María Cecilia Cimolai, Jimena Cerezo, Renata Alina Spiazzi, María Carolina Conlon, Claudia Milano et al. · 2022 · Microorganisms
  48. Integrative analysis of Paneth cell proteomic and transcriptomic data from intestinal organoids reveals functional processes dependent on autophagy
    Emily J Jones, Zoe J Matthews, Lejla Gul, Padhmanand Sudhakar, Agatha Treveil, Devina Divekar, Jasmine Buck, Tomasz Wrzesinski, Matthew Jefferson, Stuart D Armstrong et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  49. Role of ferroptosis in 2, 4, 6-trinitrobenzenesulfonic acid induced ulcerative colitis: targeting iron metabolism for therapeutic gain
    Akshata Devkar, Satish Mandlik, Deepa Mandlik · 2026 · Free Radical Research
  50. Prevalence of spondyloarthritis in inflammatory bowel disease according ASAS and ultrassonography and its correlation with plasma calprotectin
    Míriam Küster Huber, Valéria Valim, Érica Vieira Serrano, José Alexandre Mendonça, Rafael Burgomeister Lourenço, Thaisa de Moraes Ribeiro Espírito Santo, Hilde Haugedal Nordal, Maria de Fátima Bissoli, Maria Bernadete Renoldi de Oliveira Gavi · 2024 · Revista Brasileira de Reumatologia
  51. A Proteomics Pipeline for Generating Clinical Grade Biomarker Candidates from Data‐Independent Acquisition Mass Spectrometry (DIA‐MS) Discovery
    Qin Fu, Manasa Vegesna, Niveda Sundararaman, Eugen Damoc, Tabiwang N. Arrey, Anna Pashkova, Emebet Mengesha, Philip Debbas, Sandy Y. Joung, Dalin Li et al. · 2024 · Angewandte Chemie
  52. Utilization of AhR and GPR35 Receptor Ligands as Superfoods in Cancer Prevention for Individuals with IBD
    Olga Poźniak, Robert Sitarz, Monika Sitarz, Dorota Kowalczuk, Emilia Słoń, Ewa Dudzińska · 2025 · International Journal of Molecular Sciences
  53. Labordiagnostik bei chronisch-entzündlichen Darmerkrankungen, einschließlich Blut- und Stuhldiagnostik
    Thomas Klag, Eduard Friedrich Stange, Jan Wehkamp · 2014 · Die Gastroenterologie
  54. Inflammatory Markers in Children With Newly Diagnosed Inflammatory Bowel Disease
    Andrew Stewart Day, Darcy Hamilton, Steven T. Leach, Daniel A. Lemberg · 2016 · Journal of Gastroenterology and Hepatology Research
  55. Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New?
    Rayna Shentova-Eneva, Tsvetelina Veselinova Velikova · 2020 · Gastroenterology Insights
  56. Prognostic tools for identification of high risk in people with Crohn’s disease: systematic review and cost-effectiveness study
    Steven J Edwards, Samantha Barton, Mariana Bacelar, Charlotta Karner, Peter Cain, Victoria Wakefield, Gemma Marceniuk · 2021 · Health Technology Assessment
  57. Terapia nutricionais nas doenças inflamatórias intestinais: Doença de Crohn e Retocolite Ulcerativa
    Amanda Luizy Camara Santos, Bianca Christina de Oliveira Dias, Klines Alves da Silva, José Carlos de Sales Ferreira · 2021 · Research Society and Development
  58. Doença de Crohn e suas particularidades: uma revisão de literatura
    G Neto, Iangla Araújo de Melo Damasceno · 2023 · Research Society and Development
  59. Fecal metabolomics to understand intestinal dysfunction in male dairy beef calves at arrival to the rearing farm
    Anna Bassols, Núria Amigó, Marc Pérez-Rodado, Yolanda Saco, Raquel Peña, Raquel Pato, Lucía Pisoni, Maria Devant, Sònia Martí · 2025 · Scientific Reports
  60. Matrix metalloproteinases as potential fecal biomarkers for ulcerative colitis – a function beyond their proteolytic activity
    Pallavi Garg, Adani Pujada, Lewins Walter, Tanvi Dhere · 2016 · Metalloproteinases In Medicine
  61. Potential miRNAs as Diagnostic Biomarkers for Differentiating Disease States in Ulcerative Colitis: A Systematic Review
    Atta Ullah Khan, Pilar Chacon-Millan, Paola Stiuso · 2025 · International Journal of Molecular Sciences
  62. Characterizing the mediating role of metabolic signatures in the associations between air pollution exposure and inflammatory bowel disease
    Jiayue Zhang, Chengwei Chai, Lan Chen, Fei Tian, Ge Chen, Yin Yang, Yin Yang, Hualiang Lin, Zilong Zhang · 2025 · Atmospheric Environment
  63. Electrochemical biosensors for inflammatory bowel disease
    Mukhabbat Saidova, Nargiza Xamrakulova, Nodira Mirzayeva, Ilnur Аbitov, Firuza Turayeva, Barno Shagazatova, Gulchekhra Bekenova, M Butaboyev, Islom Kadirov, Bunyod Kendjaev et al. · 2025 · Clinica Chimica Acta
  64. Integrating intestinal ultrasound into routine clinical care improves prediction of biochemical disease activity in pediatric inflammatory bowel disease
    Perseus V. Patel, D Álvaro Zúñiga, Alka Goyal, Rachel Bensen, Dorsey M. Bass, Jonathan Moses, Michael J. Rosen, Ruben J. Colman · 2025 · Inflammatory Bowel Diseases
  65. Genetic Variants of DMBT1 and SFTPD and Disease Severity in Paediatric Inflammatory Bowel Disease—A Polish Population-Based Study
    Aleksandra Glapa-Nowak, Mariusz Szczepanik, Aleksandra Banaszkiewicz, Barbara Maria Iwańczak, Jarosław Kwiecień, Anna Szaflarska‐Popławska, Urszula Grzybowska‐Chlebowczyk, Marcin Osiecki, Jarosław Kierkuś, Marcin Banasiuk et al. · 2021 · Children
  66. Autoantibody Profile in Inflammatory Bowel Disease
    Aaron Lerner · 2014 · Elsevier eBooks
  67. Changes in Physiology and Pathophysiology of Calprotectin Excretion from Neonate to Adult
    Barbara Lisowska‐Myjak · 2015 · Journal of Molecular Biomarkers & Diagnosis
  68. Ani İşitme Kaybında C-Reaktif Protein Albümin Oranı ve Hematolojik Parametrelerin Prognostik Değeri
    Muhammed Gazi YILDIZ, İsrafil Orhan, Adem Doğaner · 2023 · Phoenix Medical Journal
  69. Network pharmacology analysis and animal experiment validation of inflammation inhibition by Swertiamarin in treating Ulcerative colitis
    Tang Jiafeng, Lijuan Wang, Lan Wei, You Yiqing, Yang Shiyu, Zeng Tao, Dang Tingting, Sun Haoli, Xiaoshan Li, Yan Zhang · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  70. Nanobiosensors for early diagnosis and detection of gastrointestinal diseases
    Alma Tamunonengiofori Banigo, Chinedu Chamberlin Obasi · 2025 · Elsevier eBooks
  71. Fecal calprotectin: a biomarker for intestinal inflammation
    Gian Paolo Caviglia, Giovanni Antonio Touscoz, Rinaldo Pellicano, Marco Astegiano · 2015 · Inflammation and Cell Signaling
  72. Development and validation of diagnosis model for inflammatory bowel diseases based on a serologic biomarker panel: A decision tree model study
    Junxiang Zeng, Manxiu Huai, Wensong Ge, Zhi‐gang Yang, Xiujun Pan · 2024 · Arab Journal of Gastroenterology
  73. Comparative study the levels of plasma transforming growth factor-β1, serum crp, fecal lactoferrin, and fecal calprotectin as biomarkers for disease activity in Egyptian patients with ulcerative colitis
    Arafat Kassem, Hossam Shabana, Mabrouk Mahmoud Aboelenin · 2019 · The Scientific Journal of Al-Azhar Medical Faculty Girls
  74. Serum Fetuin A and Secreted Phosphoprotein 24 as Diagnostic Markers in Inflammatory Bowel Disease
    İnanç Karakoyun, Ferruh Kemal İşman, Banu İşbilen Başok, Fatma Demet Arslan, Bülent Çalık, Nevin Genç Kahraman, Gökhan Akbulut, Celal Ulaşoğlu · 2020 · Journal of Basic and Clinical Health Sciences
  75. Gastrointestinal Toxicity Biomarkers
    Aryamitra A. Banerjee, Ramesh C. Gupta · 2019 · Elsevier eBooks
  76. Local effects of Linoorbitides and enterolactone On intestinal epithelial functions
    Ahmed A. Almousa · 2017 · University Library - University of Saskatchewan (University of Saskatchewan)
  77. How does disease location affect acute phase reactants in ulcerative colitis?
    Serkan İpek, Cem Çekiç, Emrah Alper, Hülya Yalçın, Burak Toprak, Fatih Aslan, Mahmut Arabul, Belkıs Ünsal · 2015 · International Journal of Research in Medical Sciences
  78. A new model for the discrimination between ulcerative colitis and Crohn's disease.
    Zhe Shen, Han Ma, Xiaona Shao, Chaohui Yu, Juan Du, Zun Xiang, Gan-Hua Guo, Hong Zhang, Youming Li, Min Yue · 2015 · PubMed Central
  79. Biomarcadores na Doença Inflamatória Intestinal
    Marcos Miranda da Silva · 2013 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  80. An update on clinical immunology, immune mechanisms and deficiency diseases
    Harry R. Hill · 2012 · Expert Review of Clinical Immunology
  81. Azatioprina na doença inflamatória intestinal: fatores preditivos da resposta sustentada a longo prazo
    A Sousa, Paulo M. Caldeira, Marta Eusébio, Alda Martins, Teresa Belo, Horácio Guerreiro · 2014 · GE Portuguese Journal of Gastroenterology
  82. Étude comparative de la performance de marqueurs fécaux pour la prédiction de la réponse au traitement par infliximab dans la recto colite hémorragique
    Anne Claire Frin · 2013 · HAL
  83. Specifics and Pitfalls in Diagnosis of Inflammatory Bowel Diseases
    Art Hiranyakas · 2016 · Springer eBooks
  84. Anticorps anti-Saccharomyces cerevisiae (ASCA) dans la spondyloarthrite : prévalence et phénotype associé
    Jérémy Maillet, Sébastien Ottaviani, Florence Tubach, Carine Roy, Pascale Nicaise‐Roland, Élisabeth Palazzo, Philippe Dieudé · 2017 · Revue du Rhumatisme
  85. Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy
    Tsvetelina Veselinova Velikova, R. Miladinova, Ekaterina Ivanova‐Todorova, Dobroslav Stanimirov Kyurkchiev, Z. Spasova · 2018 · Acta Medica Bulgarica
  86. Antibody-based bead arrays for high-throughput protein profiling in human plasma and serum
    Kimi Drobin · 2018 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  87. The Interleukin-1β (-511T/C) is Associated with Ulcerative Colitis
    Mayara Mansur Fernandes Tavares · 2018 · Academic Journal of Gastroenterology & Hepatology
  88. Daikenchuto improves the post-surgical albumin level and prognostic nutritional index after aortic valve replacement
    Yosuke Mukae, Kojiro Furukawa, Ryo Noguchi, Yoshimasa Oda, Akira Furutachi, Masanori Takamatsu, Manabu Itoh, Keiji Kamohara, Shigeki Morita, Takahiro Nishida · 2020 · Oriental Pharmacy and Experimental Medicine
  89. Calprotectin (S100 A8/A9) and TNF-alpha in differential diagnosis of chronic abdominal pain in children
    Stanisław Pieczarkowski, Kinga Kowalska‐Duplaga, Andrzej Wędrychowicz, Krzysztof Fyderek, Przemko Kwinta, Agnieszka Radom, Andrzej Zając, Przemysław Tomasik · 2017 · Diagnostyka Laboratoryjna
  90. Evaluation of Calprotectin Levels in First-Degree Relatives of Patients with Ulcerative Colitis
    Solmaz Razi, Katayoon Ghasemi, Mohsen Masoodi · 2021 · International Journal of Biomedical Engineering and Clinical Science
  91. Einfluss von fäkalem Calprotectin auf klinische Entscheidungen bei Patienten mit Morbus Crohn und Colitis ulcerosa
    Anna Luisa Bathe · 2021
  92. Exploration des hépatopathies et maladies digestives
    2014 · Elsevier eBooks
  93. Fecal Lactoferrin, Fecal Calprotectin, Transforming growth factor-b1, and CRP in Evaluation of Disease Activity in Egyptian patients With Ulcerative colitis
    2017 · International Journal of Current Research in Medical Sciences
  94. Specifics and Pitfalls in Diagnosis of Inflammatory Bowel Diseases
    Art Hiranyakas · 2016 · Springer eBooks
  95. PLATELET LEUKOCYTE AGGREGATES AS A PRO-THROMBOTIC RISK FACTOR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Khalil Farag, Ahmed, Abd El-Rashed Allam, Mahmoud, Fathy Abd El-Azeez, Ahmed, Ali Badr, Gamal · 2022 · Al-Azhar Medical Journal
  96. Quimiocinas e adipocinas como marcadores da atividade da doença de Crohn
    Juliana Delgado Campos Mello · 2022
  97. Advancing differential diagnosis in inflammatory bowel diseases: a combined model approach integrating erythrocyte parameters, inflammation markers, erythrocyte membranes fatty acids, and blood serum profiles
    Маргарита Витальевна Кручинина, A. I. Valuyskikh, М. Ф. Осипенко, Andrei A. Gromov, Ирина Николаевна Яковина, I. V. Osipenko · 2023 · Russian Journal of Evidence-Based Gastroenterology
  98. Upadacitinib (Rinvoq)
    CADTH · 2024 · Canadian Journal of Health Technologies
  99. Lösliches Syndecan-1 als neuer Biomarker der Entzündung bei chronisch entzündlichen Darmerkrankungen
    Mareike Clausen · 2024
  100. Causal association of blood cell traits with inflammatory bowel diseases: a Mendelian randomization study
    Fangyuan Zhang, Feiyu Jiang, Ziqin Yao, Hongbin Luo, Shoufang Xu, Yingying Zhang, Xinhui Wang, Zhiwei Liu · 2024 · Frontiers in Nutrition